Investors
-
Non Regulatory June 30, 2021Cantrixil positive Phase I trial data published in the journal Cancers
-
Non Regulatory June 28, 2021Oasmia transfers Nordic commercialization rights for Apealea® to Inceptua
-
Non Regulatory June 10, 2021First Patient enrolled in the SAKK Investigator-Initiated Phase 1b trial of Docetaxel Micellar in Advanced Prostate Cancer
Oasmia Pharmaceutical published its interim report for the first quarter of 2021 on May 27, 2021, at 08.00 am CEST.